References
- Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, Traynor BG. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10:310–23.
- HRSA. HRSA Patient Safety and Clinical Pharmacy Services Collaborative (PSPC) Charter – A Call to Action. 2010; http://www.hrsa.gov/publichealth/clinical/patientsafety/pspccharter.pdf. Accessed January 21, 2011.
- Knapp KK, Okamoto MP, Black BL. ASHP survey of ambulatory care pharmacy practice in health systems, 2004. Am J Health Syst Pharm. 2005;62:274–84.
- Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, . Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology. 1999;52:1311–23.
- Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet. 1996;347:1425–31.
- Forshew DA, Bromberg MB. A survey of clinicians’ practice in the symptomatic treatment of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4:258–63.
- Vardeny O, Bromberg MB. The use of herbal supplements and alternative therapies by patients with amyotrophic lateral sclerosis (ALS). J Herb Pharmacother. 2005;5:23–31.
- Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000. Journal of Neurology, Neurosurgery, and Psychiatry. 2003;74:1258–61.
- Smith M, Giuliano MR, Starkowski MP. In Connecticut: improving patient medication management in primary care. Health Aff (Millwood). 2011;30:646–54.
- Steurbaut S, Leemans L, Leysen T, de Baere E, Cornu P, Mets T, Dupont AG. Medication history reconciliation by clinical pharmacists in elderly inpatients admitted from home or a nursing home. Ann Pharmacother. 2010;44:1596–1603.